Potential health benefits of Indian spices in the symptoms of the metabolic syndrome: A review

Indian Journal of Biochemistry and Biophysics

Volumn 46, Issue 6, 2009, Pages 467-481

  Iyer, Abishek ^a   Panchal, Sunil ^a   Poudyal, Hemant ^a   Brown, Lindsay ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cardiovascular disease; Diabetes; Food safety; Inflammation; Metabolic syndrome; Nutraceuticals; Oxidative stress; Spices

Indexed keywords

ANIMAL; DIET THERAPY; DISEASE MODEL; HEALTH; HUMAN; INDIA; METABOLIC SYNDROME X; PATHOLOGY; REVIEW; SAFETY; SPICE;

ANIMALS; DISEASE MODELS, ANIMAL; HEALTH; HUMANS; INDIA; METABOLIC SYNDROME X; SAFETY; SPICES;

ANIMALIA; RODENTIA;

EID: 77954328796     PISSN: 03011208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (156)

1. Retelny V S, Neuendorf A & Roth J L (2008) Nutrition protocols for the prevention of cardiovascular disease. Nutr Clin Pract 23, 468-476
2. Zarraga I G E & Schwarz E R (2006) Impact of dietary patterns and interventions on cardiovascular health. Circulation 114, 961-973
3. Tapsell L C, Hemphill I., Cobiac L, Patch C S, Sullivan D R, Fenech M, Roodenrys S, Keogh J B, Clifton P M, Williams P G, Fazio V A & Inge K E (2006) Health benefits of herbs and spices: the past, the present, the future. Med J Aust 185, S4-S24
4. Vaidya A D & Devasagayam T P A (2007) Current status of herbal drugs in India: An overview. J Clin Biochem Nutr 41, 1-11
5. Modak M, Dixit P, Londhe J, Ghaskadbi S & Devasagayam T P A (2007) Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr 40, 163-173
6. Sainani G S, Desai D B, Gorhe N H, Natu S M, Pise D V & Sainani P G (1979) Dietary garlic, onion and some coagulation parameters in Jain community. J Assoc Physic India 27, 707-712
7. Chew G T, Gan S K & Watts G F (2006) Revisiting the metabolic syndrome. Med J Aust 185, 445-449
8. Moller D E & Kaufman K D (2005) Metabolic syndrome: a clinical and molecular perspective. Ann Rev Med 56, 45-62
9. Zimmet P, Magliano D, Matsuzawa Y, Alberti G & Shaw J (2005) The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 12, 295-300
10. Ramaraj R & Chellappa P (2008) Cardiovascular risk in South Asians. Postgrad Med J 84, 518-523
11. Eckel R H, Grundy S M & Zimmet P Z (2005) The metabolic syndrome. Lancet 16, 1415-1428
12. Grundy S M, Cleeman J I, Daniels S R, Donato K A, Eckel R H, Franklin B A, Gordon D J, Krauss R M, Savage P J, Smith S C Jr, Spertus J A & Costa F (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112, 2735-2752 (Pubitemid 41532612)
13. Adams R J, Appleton S, Wilson D H, Taylor A W, Dal Grande E, Chittleborough C, Gill T & Ruffin R (2005) Population comparison of two clinical approaches to the metabolic syndrome: implications of the new International Diabetes Federation consensus definition. Diabetes Care 28, 2777-2779
14. Cameron A J, Magliano D J, Zimmet P Z, Welborn T & Shaw J E (2007) The metabolic syndrome in Australia: prevalence using four definitions. Diabetes Res Clin Pract 77, 471-478
15. Park Y, Zhu S, Palaniappan L & Heshka S (2003) The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey. Arch Int Med 163, 427-436 (Pubitemid 36241019)
16. Sone H, Mizuno S, Fujii H, Yoshimura Y, Yamasaki Y, Ishibashi S, Katayama S, Saito Y, Ito H, Ohashi Y, Akanuma Y & Yamada Y (2005) Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in Asian diabetic patients? Diabetes Care 28, 1463-1471
17. Parikka P, Eriksson J, Lindstrom J, Hamalainen H, Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Rastas M, Salminen V, Aunola S, Sundvall J, Valle T, Lahtela J, Uusitupa M & Tuomilehto J (2004) Prevalence of the metabolic syndrome and its components. Diabetes Care 27, 2135-2140
18. Misra A & Khurana L (2008) Obesity and the metabolic syndrome in developing countries. J Clin Endocrin Metabol 93, S9-S30
19. Misra A, Khurana L, Isharwal S & Bhardwaj S (2009) South Asian diets and insulin resistance. Br J Nutr 101, 465-473
20. Hydrie M Z I, Shera A S, Fawwad A, Basit A & Hussain A (2009) Prevalence of metabolic syndrome in urban Pakistan (Karachi): Comparison of newly proposed International Diabetes Federation and modified Adult Treatment Panel III criteria. Metab Syndr Relat Disord 7, 119-124
21. Basit A & Shera A S (2008) Prevalence of metabolic syndrome in Pakistan. Metab Syndr Relat Disord 6, 171-175
22. Alberti K G & Zimmet P Z (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15, 539-553
23. Balkau B & Charles M A (1999) Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16, 442-443
24. Einhorn D, Reaven G M, Cobin R H, Ford E, Ganda O P, Handelsman Y, Hellman R, Jellinger P S, Kendall D, Krauss R M, Neufeld N D, Petak S M, Rodbard H W, Seibel J A, Smith D A & Wilson P W (2003) American College of Endocrinology position statement on the insulin resistance syndrome. Endocrin Pract 9, 237-252
25. Grundy S M, Brewer H B Jr, Cleeman J I, Smith S C Jr & Lenfant C (2004) Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109, 433-438
26. Alberti K G, Zimmet P & Shaw J (2005) The metabolic syndrome - a new worldwide definition. Lancet 366, 1059-1062 (Pubitemid 41338752)
27. Van Gaal L F, Mertens I L & de Block C E (2006) Mechanisms linking obesity with cardiovascular disease. Nature 444, 875-880
28. Hajer G R, van Haeften T W & Visseren F L J (2008) Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 29, 2959-2971
29. Dandona P, Chaudhuri A, Ghanim H & Mohanty P (2006) Anti-inflammatory effects of insulin and the proinflammatory effects of glucose. Semin Thorac Cardiovasc Surg 18, 293-301
30. Govindarajan G, Alpert M A & Tejwani L (2008) Endocrine and metabolic effects of fat: cardiovascular implications. Am J Med 121, 366-370
31. Dandona P, Aljada A, Chaudhuri A, Mohanty P & Rajesh G (2004) A novel view of metabolic syndrome. Metab Syndr Relat Disord 2, 2-8
32. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M & Shimomura I (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114, 1752-1761
33. Park J, Chung J J & Kim J B (2007) New evaluations of redox regulating system in adipose tissue of obesity. Diabetes Res Clin Pract 77, S11-S16
34. Haddad J J (2002) Redox regulation of pro-inflammatory cytokines and IkappaB-alpha/NF-kappaB nuclear translocation and activation. Biochem Biophys Res Commun 296, 847-856
35. Sukkar S G & Rossi E (2003) Oxidative stress and nutritional prevention in autoimmune rheumatic diseases. Autoimmun Rev 3, 199-206
36. Aggarwal B B & Shishodia S (2004) Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann N Y Acad Sci 1030, 434-441
37. Buettner R, Schlmerich J & Bollheimer L C (2007) Development and application of rodent models for type II diabetes. Obesity 15, 798-808
38. Chen D & Wang M (2005) Development and application of rodent models for type II diabetes. Diabetes Obes Metab 7, 307-317
39. Doggrell S A & Brown L (1998) Rat models of hypertension, cardiac hypertrophy and failure. Cardiovasc Res 39, 89-105 (Pubitemid 28322382)
40. Tesch G H & Allen T J (2007) Rodent models of streptozotocin-induced diabetic nephropathy. Nephrology (Carlton) 12, 261-266
41. Anuradha C V & Balakrishnan S D (1999) Taurine attenuates hypertension and improves insulin sensitivity in the fructose-fed rat, an animal model of insulin resistance. Can J Physiol Pharmacol 77, 749-754
42. Thirunavukkarasu V, Balakrishnan S D, Ravichandran M K & Anuradha C V (2003) Influence of 6-week exercise training on erythrocyte and liver antioxidant defense in hyperinsulinemic rats. Comp Biochem Physiol C Toxicol Pharmacol 135, 31-37
43. Kawano K, Hirashima T, Mori S & Natori T (1994) OLETF (Otsuka Long-Evans Tokushima Fatty) rat: a new NIDDM rat strain. Diabetes Res Clin Pract 24, S317-S320
44. Mizushige K, Yao L, Noma T, Kiyomoto H, Yu Y, Hosomi N, Ohmori K & Matsuo H (2000) Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation 101, 899-907
45. Bitar M, Al-Saleh E & Al-Mulla F (2005) Oxidative stressmediated alterations in glucose dynamics in a genetic animal model of type II diabetes. Life Sci 77, 2552-2573
46. Flamment M, Arvier M, Gallois Y, Simard G, Malthiery Y, Ritz P & Ducluzeau P (2008) Fatty liver and insulin resistance in obese Zucker rats: No role for mitochondrial dysfunction. Biochimie 90, 1407-1413
47. Liu R, Mizuta M, Kurose T & Matsukura S (2002) Early events involved in the development of insulin resistance in Zucker fatty rats. Int J Obes Relat Metab Disord 26, 318-326
48. Richardson M, Schmidt A, Graham S, Achen B, DeReske M & Russell J C (1998) Vasculopathy and insulin resistance in the JCR:LA-cp rat. Atherosclerosis 138, 135-146
49. Russell J, Proctor S, Kelly S & Brindley D (2008) Pair feeding-mediated changes in metabolism: stress response and pathophysiology in insulin-resistant, atherosclerosis-prone JCR:LA-cp rats. Am J Physiol Endocrin Metab 294, E1078-E1087
50. Cacanyiova S & Kristek F (2008) Adaptive vasoactive response to modulatory effects of endothelin-1 in spontaneously hypertensive rats Pharmacol Rep 60, 941-949
51. Ren J & Ma H (2008) Impaired cardiac function in leptindeficient mice. Curr Hypertens Rep 10, 448-453
52. Carley A N & Severson D L (2008) What are the biochemical mechanisms responsible for enhanced fatty acid utilization by perfused heart from type 2 diabetic db/db mice? Cardiovasc Drugs Ther 22, 83-89
53. Baudry A, Leroux L, Jackerott M & Joshi R (2002) Genetic manipulation of insulin signalling, action and secretion in mice. EMBO Rep 3, 323-328
54. Katz E, Stanbit A, Hatton K, De Pinho R & Charron M (1995) Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4 Nature 377, 151-155
55. Araki E, Lipes M, Patti M, Bruning J, Haag B, Johnson R & Kahn C (1994) Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372, 186-190
56. Giani J, Mayer M, Muñoz M, Silberman E, Hocht C, Taira C, Gironacci M, Turyn D & Dominici F (2009) Chronic infusion of angiotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats. Am J Physiol Endocrinol Metab 296, E262-E271
57. Maiztegui B, Borelli M, Raschia M, Del Zotto H & Gagliardino J J (2009) Islet adaptive changes to fructoseinduced insulin resistance: beta-cell mass, glucokinase, glucose metabolism, and insulin secretion. J Endocrinol 200, 139-149
58. Chicco A G, D'Allesandro M E, Hein G J, Oliva M E & Lombardo Y B (2009) Dietary chia seed (Salvia hispanica L.) rich in alpha-linolenic acid improves adiposity and normalises hypertriglycerolaemia and insulin resistance in dyslipaemic rats. Br J Nutr 101, 41-50
59. Bourgoin F, Bachelard H, Badeau M, Mélançon S, Pitre M, Larivière R & Nadeau A (2008) Endothelial and vascular dysfunctions and insulin resistance in rats fed a high fat high sucrose diet. Am J Physiol Heart Circulation Physiol 295, H1044-H1055
60. Mariotti F, Hermier D, Sarrat C, Magné J, Fénart E, Evrard J, Tomé D & Huneau J (2008) Rapeseed protein inhibits the initiation of insulin resistance by a high saturated fat, highsucrose diet in rats. Br J Nutr 100, 984-991
61. Srinivasan K (2005) Plant foods in the management of diabetes mellitus: spices as beneficial antidiabetic food adjuncts. Int J Food Sci Nutr 56, 399-414
62. Kelly G S (2000) Insulin resistance: lifestyle and nutritional interventions. Altern Med Rev 5, 109-132
63. Mashour N H, Lin G I & Frishman W H (1998) Herbal medicine for the treatment of cardiovascular disease. Clinical consideration. Arch Intern Med 158, 2225-2234
64. Talhouk R S, Karam C, Fostok S, El-Jouni W & Barbour E K (2007) Anti-inflammatory bioactivities in plant extracts. J Med Food 10, 1-10
65. Shaban M A E, Kandeel K M, Yacout G A & Mehaseb S E (1987) The chemical composition of the volatile oil of Elettaria cardamomum seeds. Pharmazie 42, 207-208
66. Noleau I, Toulemonde B & Richard H (1987) Volatile constituents of cardamom Elettaria cardamomum Maton cultivated in Costa Rica. Flavour Frag J 2, 123-127
67. Gopalakrishnan M, Narayanan C S & Grenz M (1990) Non saponifiable lipid constituents of cardamom. J Agric Food Chem 38, 2133-2136
68. Duke J A (1992) Handbook of Phytochemical Constituents of GRAS Herbs and other Economic Plants: Herbal reference library, pp 239-240, CRC Press, London
69. Suneetha W J & Krishnakantha T P (2005) Cardamom extract as inhibitor of human platelet aggregation. Phytother Res 19, 437-440
70. Gilani A H, Jabeen Q, Khan A U & Shah A J (2008) Gut modulatory, blood pressure lowering, diuretic and sedative activities of cardamom. J Ethnopharmacol 115, 463-472
71. Dugoua J J, Seely D, Perri D, Cooley K, Forelli T, Mills E & Koren G (2007) From type 2 diabetes to antioxidant activity: a systematic review of the safety and efficacy of common and cassia cinnamon bark. Can J Physiol Pharmacol 85, 837-847
72. Lopez P, Sanchez C, Battle R & Nerin C (2005) Solid-and vapor-phase antimicrobial activities of six essential oils: susceptibility of selected foodborne bacterial and fungal strains. J Agric Food Chem 53, 6939-6946
73. Shan B, Cai Y Z, Sun M & Corke H (2005) Antioxidant capacity of 26 spice extracts and characterization of their phenolic constituents. J Agric Food Chem 53, 7749-7759
74. Anderson R A, Broadhurst C L, Polansky M M, Schmidt W F, Khan A, Flanagan V P, Schoene N W & Graves D J (2004) Isolation and characterization of polyphenol type-A polymers from cinnamon with insulinlike biological activity. J Agric Food Chem 52, 65-70
75. Khan A, Safdar M, Ali Khan M M, Khattak K N & Anderson R A (2003) Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 26, 3215-3218
76. Verspohl E J, Bauer K & Neddermann E (2005) Antidiabetic effect of Cinnamomum cassia and Cinnamomum zeylanicum in vivo and in vitro. Phytother Res 19, 203-206
77. Preuss H G, Echard B, Polansky M M & Anderson R (2006) Whole cinnamon and aqueous extracts ameliorate sucroseinduced blood pressure elevations in spontaneously hypertensive rats. J Am Coll Nutr 25, 144-150
78. Qin B, Nagasaki M, Ren M, Bajotto G, Oshida Y & Sato Y (2004) Cinnamon extract prevents the insulin resistance induced by a high-fructose diet. Horm Metab Res 36, 119-125
79. Kannappan S, Jayaraman T, Rajasekar P, Ravichandran M K & Anuradha C V (2006) Cinnamon bark extract improves glucose metabolism and lipid profile in the fructose-fed rat. Singapore Med J 47, 858-863
80. Lee H (2005) Cuminaldehyde: aldose reductase and α-glucosidase inhibitor derived from Cuminum cyminum L. seeds. J Agric Food Chem 53, 2446-2450
81. Babu S P & Prabusreenivasan S (2007) Cinnamaldehyde - a potential anti-diabetic agent. Phytomedicine 14, 15-22
82. Mang B, Wolters M, Schmitt B, Kelb K, Lichtinghagen R, Stichtenoth D O & Hahn A (2006) Effects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2. Eur J Clin Invest 36, 340-344
83. Solomon T P & Blannin A K (2009) Changes in glucose tolerance and insulin sensitivity following 2 weeks of daily cinnamon ingestion in healthy humans. Eur J Appl Physiol 105, 969-976
84. Ziegenfuss T N, Hofheins J E, Mendel R W, Landis J & Anderson R A (2006) Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women. J Int Soc Sports Nutr 3, 45-53
85. Jabeen Q, Bashir S, Lyoussi B & Gilani A (2009) Coriander fruit exhibits gut modulatory, blood pressure lowering and diuretic activities. J Ethnopharmacol 122, 123-130
86. Bajpai M, Mishra A & Prakash D (2005) Antioxidant and free radical scavenging activities of some leafy vegetables. Int J Food Sci Nutr 56, 473-481
87. Swanston-Flatt S, Day C, Bailey C & Flatt P (1990) Traditional plant treatments for diabetes: Studies in normal and streptozotocin-diabetic mice. Diabetologia 33, 462-464
88. Chithra V & Leelamma S (1997) Hypolipidemic effect of coriander seeds (Coriandrum sativum): mechanism of action. Plant Foods Hum Nutr 51, 167-172
89. Aissaoui A, El-Hilaly J, Israili Z & Lyoussi B (2008) Acute diuretic effect of continuous intravenous infusion of an aqueous extract of Coriandrum sativum L. in anesthetized rats. J Ethnopharmacol 115, 89-95
90. Eidi M, Eidi A, Saeidi A, Molanaei S, Sadeghiour A, Bahar M & Bahar K (2008) Effect of coriander seed (Coriandrum sativum L.) ethanol extract on insulin release from pancreatic beta cells in streptozotocin-induced diabetic rats. Phytother Res 23, 404-406
91. Suliman S, Elmahdi B & Abuelgasim A (2008) The effect of feeding Coriandrum sativum fruits powder on the plasma lipids profile in cholesterol-fed rats. Res J Ani & Vet Sci 3, 24-28
92. Roman-Ramos R, Flores-Saenz J, Alarcon-Aguilar F J (1995) Antihyperglycaemic effect of some edible plants. J Ethnopharmacol 48, 251-255
93. Dhandapani S, Subramanian V, Rajagopal S & Namasivayam N (2002) Hypolipidemic effect of Cuminum cyminum L. on alloxan-induced diabetic rats. Pharmacol Res 46, 251-255
94. Willatgamuwa S, Patel K, Saraswati G & Srinivasan K (1998) Antidiabetic influence of dietary cumin seeds (Cuminum cyminum) in streptozotocin-induced diabetic rats. Nutr Res 18, 131-142
95. Wang Y S, He H P, Shen Y M, Hong X & Hao X J (2003) Two new carbazole alkaloids from Murraya koenigii. J Nat Prod 66, 416-418
96. Ningappa M B & Srinivas L (2008) Purification and characterization of approximately 35 kDa antioxidant protein from curry leaves (Murraya koenigii L.). Toxicol In Vitro 22, 699-709
97. Xie J T, Chang W T, Wang C Z, Mehendale S R, Li J, Ambihaipahar R, Ambihaipahar U, Fong H H & Yuan C S (2006) Curry leaf (Murraya koenigii Spreng.) reduces blood cholesterol and glucose levels in ob/ob mice. Am J Chin Med 34, 279-284
98. Kesari A N, Gupta R K & Watal G (2005) Hypoglycemic effects of Murraya koenigii on normal and alloxan-diabetic rabbits. J Ethnopharmacol 97, 247-251
99. Yadav S, Vats V, Dhunnoo Y & Grover J K (2002) Hypoglycemic and antihyperglycemic activity of Murraya koenigii leaves in diabetic rats. J Ethnopharmacol 82, 111-116
100. Khan B A, Abraham A & Leelamma S (1995) Hypoglycemic action of Murraya koenigii (curry leaf) and Brassica juncea (mustard): mechanism of action. Indian J Biochem Biophys 32, 106-108
101. Khan B A, Abraham A & Leelamma S (1997) Anti-oxidant effects of curry leaf, Murraya koenigii and mustard seeds, Brassica juncea in rats fed with high fat diet. Indian J Exp Biol 35, 148-150
102. Khan B A, Abraham A & Leelamma S (1996) Biochemical response in rats to the addition of curry leaf (Murraya koenigii) and mustard seeds (Brassica juncea) to the diet. Plant Foods Hum Nutr 49, 295-299
103. Yoshikawa M, Murakami T, Komatsu H, Murakami N, Yamahara J & Matsuda H (1997) Medicinal foodstuffs. IV. Fenugreek seed. (1): structures of trigoneosides Ia, Ib, IIa, IIb, IIIa, and IIIb, new furostanol saponins from the seeds of Indian Trigonella foenum-graecum L. Chem Pharm Bull (Tokyo) 45, 81-87
104. Ahmadiani A, Javan M, Semnanian S, Barat E & Kamalinejad M (2001) Anti-inflammatory and antipyretic effects of Trigonella foenum-graecum leaves extract in the rat. J Ethnopharmacol 75, 283-286
105. Petit P R, Sauvaire Y D, Hillaire-Buys D M, Leconte O M, Baissac Y G, Ponsin G R & Ribes G R (1995) Steroid saponins from fenugreek seeds: extraction, purification, and pharmacological investigation on feeding behavior and plasma cholesterol. Steroids 60, 674-680
106. Sauvaire Y, Baissac Y, Leconte O, Petit P & Ribes G (1996) Steroid saponins from fenugreek and some of their biological properties. Adv Exp Med Biol 405, 37-46
107. Raghuram T C, Sharma R D, Sivakumar B & Sahay B K (1994) Effect of fenugreek seeds on intravenous glucose disposition in non-insulin-dependent diabetic-patients. Phytother Res 8, 83-86
108. Srichamroen A, Field C J, Thomson A B R & Basu T K (2008) The modifying effects of galactomannan from Canadian-grown fenugreek (Trigonella foenum-graecum L.) on the glycemic and lipidemic status in rats. J Clin Biochem Nutr 43, 167-174
109. Sharma R D, Raghuram T C & Rao N S (1990) Effect of fenugreek seeds on blood-glucose and serum-lipids in type-I diabetes. Eur J Clin Nutr 44, 301-306
110. Sharma R D, Sarkar A, Hazra D K, Mishra B, Singh J B, Sharma S K, Maheshwari B B & Maheshwari P K (1996) Use of fenugreek seed powder in the management of noninsulin dependent diabetes mellitus. Nutr Res 16, 1331-1339
111. Fairchild R M, Ellis P R, Byrne A J, Luzio S D & Mir M A (1996) A new breakfast cereal containing guar gum reduces postprandial plasma glucose and insulin concentrations in normal-weight human subjects. Br J Nutr 76, 63-73
112. Sels J P, Flendrig J A & Postmes T J (1987) The influence of guar gum bread on the regulation of diabetes mellitus type II in elderly patients. Br J Nutr 57, 177-180
113. Landin K, Holm G, Tengborn L & Smith U (1992) Guar gum improves insulin sensitivity, blood-lipids, blood-pressure, and fibrinolysis in healthy-men. Am J Clin Nutr 56, 1061-1065
114. Agarwal K C (1996) Therapeutic actions of garlic constituents. Med Res Rev 16, 111-124
115. Augusti K T (1996) Therapeutic values of onion (Allium cepa L.) and garlic (Allium sativum L.). Indian J Exp Biol 34, 634-640
116. Campbell J H, Efendy J L, Smith N J & Campbell G R (2001) Molecular basis by which garlic suppresses atherosclerosis. J Nutr 131, 1006S-1009S
117. Banerjee S K, Mukherjee P K & Maulik S K (2003) Garlic as an antioxidant: the good, the bad and the ugly. Phytother Res 17, 97-106
118. Al-Qattan K K, Khan I, Alnaqeeb M A & Ali M (2003) Mechanism of garlic (Allium sativum) induced reduction of hypertension in 2K-1C rats: a possible mediation of Na/H exchanger isoform-1. Prostaglandins Leukot Essent Fatty Acids 69, 217-222
119. Benavides G A, Squadrito G L, Mills R W, Patel H D, Isbell T S, Patel R P, Darley-Usmar V M, Doeller J E & Kraus D W (2007) Hydrogen sulfide mediates the vasoactivity of garlic. Proc Natl Acad Sci USA 104, 17977-17982
120. Kaye A D, De Witt B J, Anwar M, Smith D E, Feng C J, Kadowitz P J & Nossaman B D (2000) Analysis of responses of garlic derivatives in the pulmonary vascular bed of the rat. J Appl Physiol 89, 353-358
121. Banerjee S K, Dinda A K, Manchanda S C & Maulik S K (2002) Chronic garlic administration protects rat heart against oxidative stress induced by ischemic reperfusion injury. BMC Pharmacol 2, 16
122. Banerjee S K, Maulik M, Manchanda S C, Dinda A K, Das T K & Maulik S K (2001) Garlic-induced alteration in rat liver and kidney morphology and associated changes in endogenous antioxidant status. Food Chem Toxicol 39, 793-797
123. Prasad K, Laxdal V A, Yu M & Raney B L (1996) Evaluation of hydroxyl radical-scavenging property of garlic. Mol Cell Biochem 154, 55-63
124. Reinhart K M, Coleman C I, Teevan C, Vachhani P & White C M (2008) Effects of garlic on blood pressure in patients with and without systolic hypertension: a metaanalysis. Ann Pharmacother 42, 1766-1771
125. Ried K, Frank O R, Stocks N P, Fakler P & Sullivan T (2008) Effect of garlic on blood pressure: a systematic review and meta-analysis. BMC Cardiovasc Disord 16, 13
126. Pittler M H & Ernst E (2007) Clinical effectiveness of garlic (Allium sativum). Mol Nutr Food Res 51, 1382-1385
127. Afzal M, Al-Hadidi D, Menon M, Pesek J & Dhami M S (2001) Ginger: an ethnomedical, chemical and pharmacological review. Drug Metabol Drug Interact 18, 159-190
128. Ali B H, Blunden G, Tanira M O & Nemmar A (2008) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Food Chem Toxicol 46, 409-420
129. Grzanna R, Lindmark L & Frondoza C G (2005) Ginger - an herbal medicinal product with broad anti-inflammatory actions. J Med Food 8, 125-132
130. Ghayur M N & Gilani A H (2005) Ginger lowers blood pressure through blockade of voltage-dependent calcium channels. J Cardiovasc Pharmacol 45, 74-80
131. Jena B S, Jayaprakasha G K, Singh R P & Sakariah K K (2002) Chemistry and biochemistry of (-)-hydroxycitric acid from Garcinia. J Agric Food Chem 50, 10-22
132. Tomita K, Okuhara Y, Shigematsu N, Suh H & Lim K (2003) Hydroxycitrate ingestion increases fat oxidation during moderate intensity exercise in untrained men. Biosci Biotechnol Biochem 67, 1999-2001
133. Kim K Y, Lee H N, Kim Y J & Park T (2008) Garcinia cambogia extract ameliorates visceral adiposity in C57BL/6J mice fed on a high-fat diet. Biosci Biotechnol Biochem 72, 1772-1780
134. Asghar M, Monjok E, Kouamou G, Ohia S E, Bagchi D & Lokhandwala M F (2007) Super CitriMax (HCA-SX) attenuates increases in oxidative stress, inflammation, insulin resistance, and body weight in developing obese Zucker rats. Mol Cell Biochem 304, 93-99
135. Preuss H G, Rao C V, Garis R, Bramble J D, Ohia S E, Bagchi M & Bagchi D (2004) An overview of the safety and efficacy of a novel, natural (-)-hydroxycitric acid extract (HCA-SX) for weight management. J Med 35, 33-48
136. Itokawa H, Shi Q, Akiyama T, Morris-Natschke S L & Lee K H (2008) Recent advances in the investigation of curcuminoids. Chin Med 3, 11
137. Jain S K, Rains J & Jones K (2006) Effect of curcumin on protein glycosylation, lipid peroxidation, and oxygen radical generation in human red blood cells exposed to high glucose levels. Free Radic Biol Med 41, 92-96
138. Lee Y K, Lee W S, Hwang J T, Kwon DY, Surh Y J & Park O J (2009) Curcumin exerts antidifferentiation effect through AMPKalpha-PPAR-gamma in 3T3-L1 adipocytes and antiproliferatory effect through AMPKalpha-COX-2 in cancer cells. J Agric Food Chem 57, 305-310
139. Gonzales A M & Orlando R A (2008) Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes. Nutr Metab (Lond) 5, 17
140. Weisberg S P, Leibel R & Tortoriello D V (2008) Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocrinology 149, 3549-3558
141. Asai A & Miyazawa T (2001) Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue. J Nutr 131, 2932-2935
142. Ramírez-Tortosa M C, Mesa M D, Aguilera M C, Quiles J L, Baró L, Ramirez-Tortosa C L, Martinez-Victoria E & Gil A (1999) Oral administration of a turmeric extract inhibits LDL oxidation and has hypocholesterolemic effects in rabbits with experimental atherosclerosis. Atherosclerosis 147, 371-378
143. Srivastava R, Dikshit M, Srimal R C & Dhawan B N (1985) Anti-thrombotic effect of curcumin. Thromb Res 40, 413-417
144. Miquel J, Bernd A, Sempere J M, Díaz-Alperi J & Ramírez A (2002) The curcuma antioxidants: pharmacological effects and prospects for future clinical use. A review. Arch Gerontol Geriatr 34, 37-46
145. Strimpakos A S & Sharma R A (2008) Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid Redox Signal 10, 511-545
146. Vijayakumar R S, Surya D & Nalini N (2004) Antioxidant efficacy of black pepper (Piper nigrum L.) and piperine in rats with high fat diet induced oxidative stress. Redox Rep 9, 105-110
147. Westerterp-Plantenga M, Diepvens K, Joosen A M, Bérubé- Parent S & Tremblay A (2006) Metabolic effects of spices, teas, and caffeine. Physiol Behav 89, 85-91
148. Yang S, Na M K, Jang J P, Kim K A, Kim BY, Sung N J Oh W K & Ahn J (2006) Inhibition of protein tyrosine phosphatase 1B by lignans from Myristica fragrans. Phytother Res 20, 680-682
149. Ram A, Lauria P, Gupta R & Sharma V N (1996) Hypolipidaemic effect of Myristica fragrans fruit extract in rabbits. J Ethnopharmacol 55, 49-53
150. Sharma A, Mathur R & Dixit V P (1995) Prevention of hypercholesterolemia and atherosclerosis in rabbits after supplementation of Myristica fragrans seed extract. Indian J Physiol Pharmacol 39, 407-410
151. Vanschoonbeek K, Thomassen B J, Senden J M, Wodzig W K & van Loon L J (2006) Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetic patients. J Nutr 136, 977-980
152. Kartal M (2007) Intellectual property protection in the natural product drug discovery, traditional herbal medicine and herbal medicinal products. Phytother Res 21, 113-119
153. Jayaraman K S (2009) India protects traditional medicines from piracy. Access to national database eases search for existing treatments. Nature doi:10.1038/news.2009.107
154. Hu Z, Yang X, Ho P C L, Chan S Y, Heng P W S, Chan E, Duan W, Koh H L & Zhou S (2005) Herb-drug interactions. A literature review. Drugs 65, 1239-1282
155. Murch S J, Krishnaraj S & Saxena P K (2000) Phytopharmaceuticals: Problems, limitations, and solutions. Sci Rev Altern Med 4, 33-37
156. Katan M B & De Roos N M (2004) Promises and problems of functional foods. Crit Rev Food Sci Nutr 44, 369-377